NCT05916625View on ClinicalTrials.gov

Exploratory Study of the Expression of the Serotonergic 5-HT4 Receptor in Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 7, 2023

Primary Completion Date

September 29, 2025

Study Completion Date

September 29, 2025

Conditions
Parkinson Disease
Interventions
OTHER

neuropsychological assessment

a consultation to assess cognitive and psycho-behavioral functions with questionnaires

OTHER

biological sample

10 mL intravenous whole blood collection in EDTA tube

PROCEDURE

medical imagery

Pet scan with the specific radioligand \[11C\]SB207145 and MRI

Trial Locations (2)

69500

CERMEP, Bron

Unknown

"Hôpital des Charpennes Centre de Recherche Clinique Vieillissement-Cerveau-Fragilité", Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT05916625 - Exploratory Study of the Expression of the Serotonergic 5-HT4 Receptor in Parkinson's Disease | Biotech Hunter | Biotech Hunter